BDBM202277 5,8-dimethyl-2-(2-(6-(pyrrolidin-1-yl)pyrazin-2-yl)ethyl)-[1,2,4]triazolo[1,5-a]pyrazine::US9540384, 51
SMILES: Cc1cnc(C)c2nc(CCc3cncc(n3)N3CCCC3)nn12
InChI Key: InChIKey=BRETULWUCTYGEY-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM202277 (5,8-dimethyl-2-(2-(6-(pyrrolidin-1-yl)pyrazin-2-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | 25 |
Hoffmann-La Roche, Inc. US Patent | Assay Description The human PDE10A full length assay was performed in 96-well micro titer plates. The reaction mixture of 50 .mu.l contained 20 mM HEPES pH=7.5/10 mM M... | US Patent US9540384 (2017) BindingDB Entry DOI: 10.7270/Q2HT2MG1 | |||||||||||
More data for this Ligand-Target Pair |